Cancer Home > Ofatumumab
Ofatumumab is a medication prescribed for treating a certain type of cancer known as chronic lymphocytic leukemia (CLL). It is used in people who have not responded to or cannot take certain other chemotherapy treatment. The intravenous infusion is administered by a healthcare provider once every one to four weeks. Side effects may include infections, fever, and coughing.
What Is Ofatumumab?Ofatumumab (Arzerra®) is a prescription medication approved to treat a certain type of leukemia (cancer of the blood and bone marrow) known as chronic lymphocytic leukemia (CLL). It is reserved for use in people who tried and failed treatment with alemtuzumab (Campath®) and fludarabine (Fludara®) or, when combined with chlorambucil, for previously untreated people who are not good candidates for fludarabine-based treatment. Ofatumumab belongs to a group of medicines known as monoclonal antibodies.
Are There Side Effects?Just like any medicine, ofatumumab may cause side effects, and some of them can be significant. In fact, most people who use the drug will experience some type of side effect during treatment.
- Decreased blood cell counts